内镜经蝶窦垂体瘤术后口服抗生素对鼻窦结局的影响:多中心前瞻性随机双盲安慰剂对照研究
该多中心前瞻性随机双盲安慰剂对照研究纳入131例内镜经鼻蝶窦垂体瘤手术患者,随机接受术后7天口服抗生素(头孢地尼或复方磺胺甲噁唑)或安慰剂,随访12周。结论认为术后预防性口服抗生素并未改善鼻窦生活质量。
要点
- 术后预防性口服抗生素未改善内镜经蝶窦垂体瘤手术患者的鼻窦生活质量。
- 鼻内镜愈合评分在术后1-2周和3-4周两组间亦无显著差异。
核心结论
- 对于标准内镜经蝶窦垂体瘤手术患者,术后预防性口服抗生素相比安慰剂并未带来更优的鼻窦生活质量。
研究设计与样本
- 多中心、前瞻性、随机、双盲、安慰剂对照研究。
- 共筛查461例,随机131例,最终分析113例(安慰剂组55例,抗生素组58例)。
- 术后口服安慰剂或头孢地尼(不耐受者用复方磺胺甲噁唑)7天,随访12周。
临床怎么用
- 内镜经蝶窦垂体瘤术后不应常规预防性口服抗生素以改善鼻窦生活质量。
- 该结果支持抗生素管理,减少不必要的术后抗生素使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative prophylactic antibiotics are commonly used in pituitary surgery, but evidence supporting their use is lacking, which has implications for antibiotic stewardship. OBJECTIVE: To evaluate whether receipt of postoperative oral antibiotics results in superior sinonasal quality of life (QOL) compared with placebo among patients who undergo endoscopic endonasal transsphenoidal pituitary surgery. METHODS: Patients were randomized to receive either oral placebo or cefdinir (trimethoprim-sulfamethoxazole in patients intolerant to cefdinir) for 7 d after surgery. They were monitored for 12 wk. The primary outcome measure was sinonasal QOL at 2 wk on the Anterior Skull Base Nasal Inventory-12. Supplementary end points included sinonasal QOL reported on the Sinonasal Outcome Test-22 and objective endoscopy scores to assess nasal healing according to the Lund-Kennedy method. RESULTS: A total of 461 patients were screened, 131 were randomized, and 113 (placebo arm: 55; antibiotic arm: 58) were analyzed. There was no clinically meaningful or statistically significant difference in sinonasal QOL at any measured time point (P ≥ .24) using either instrument. Nasal cavity endoscopy scores were not significantly different at 1 to 2 wk after surgery (P = .25) or at 3 to 4 wk after surgery (P = .08). CONCLUSION: Postoperative prophylactic oral antibiotics did not result in superior sinonasal QOL compared with placebo among patients who underwent standard endoscopic transsphenoidal surgery.
引用
- Little AS, Kshettry VR, Rosen MR, et al. Postoperative Oral Antibiotics and Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Tumors Study: A Multicenter, Prospective, Randomized, Double-Blinded, Placebo-Controlled Study. Neurosurgery. 2021. PMID: 34411264. doi:10.1093/neuros/nyab301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。